Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 805 results for "ipf"

Transaction in Own Shares

Regulatory Story - IPF Released 07:00 21-Oct-2014 RNS Number : 8035U 21 October 2014  21 October 2014 INTERNATIONAL PERSONAL FINANCE PLC TRANSACTION IN OWN SHARES International Personal Finance plc announces that on 20 October 2014 it purchased, ... London Stock Exchange, 2 days ago

24 images for ipf, 1 day ago
GlobeNewswire, 1 day ago, 1 week ago
Drug Discovery and Development, 1 week ago
Mideast Time, 16 hours ago
Securities Technology Monitor, 1 day ago
Ziarul Financiar, 1 day ago
Pharmafocus, 2 days ago
Bioresearch Online, 4 days ago
Indiana News Center, 6 days ago
Bioresearch Online

PROMETIC LIFE SCIENCES : PBI-4050 to Target Idiopathic Pulmonary Fibrosis "IPF" as One of Its Orphan Indications

By a News Reporter-Staff News Editor at Clinical Trials Week -- ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF) (" ProMetic " or the "Corporation") announced that it will be pursuing IPF as one of its PBI-4050 orphan indications. This decision ...
 4 Traders1 day ago ProMetic Life Sciences to initiate IPF clinical program in Canada  Individual.com3 days ago ProMetic Seeks Orphan Status For Lead IPF Drug  Bioresearch Online4 days ago ProMetic Life Sciences Inc. (PFSCF: OTCQX International) | ProMetic's PBI-4050 to Target Idiopathic Pulmonary Fibrosis ("IPF") as One of Its Orphan Indications  Pink Sheets1 week ago

Improving care for patients with idiopathic pulmonary fibrosis (IPF) in the UK: a round table discussion

1 , Clare Kendall 2 , Lisa G Spencer 3 , Nick Screaton 4 , William A Wallace 5 , Hilary Pinnock 6 , Julia Bott 7 , Lucy Pigram 8 , Sarah Watson 9 , Ann B Millar 10 1 Centre for Translational Inflammation and Fibrosis Research, University ...
 British Journal of the Thorax2 days ago
Daily Rx

FDA Approves Two Targeted Therapies To Treat Idiopathic Pulmonary Fibrosis

Rockville, MD—The FDA has approved two products to treat idiopathic pulmonary fibrosis (IPF), a condition in which the lungs become progressively scarred over time. More than 100,000 people in the United States have IPF, an irreversible and ...
 Pharmacy Practice News6 days ago FDA approves two treatments from Roche, Boehringer for fatal lung disorder  CNBC1 week ago Good day for sufferers of IPF  Seeking Alpha1 week ago FDA Approves Two Medications for Idiopathic Pulmonary Fibrosis  Daily Rx1 week ago
MedPage Today

FDA Approves Esbriet® pirfenidone for the Treatment of Idiopathic Pulmonary Fibrosis IPF in the United States

By a News Reporter-Staff News Editor at Biotech Week -- Genentech , a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced that the U.S. Food and Drug Administration (FDA) has approved Esbriet® (pirfenidone) as a treatment for ...
 4 Traders1 day ago FDA Approves Two Drugs for IPF  Pharmaceutical Manufacturing Magazine3 days ago Roche's Esbriet Gets US FDA Nod for IPF Treatment  PharmaAsia3 days ago OFEV® (nintedanib) Now Available In The United States  TheStreet.com3 days ago

AGIO At New High, TRIV Applauded, FDA Approves 2 Drugs For IPF, INSY Falls

Advaxis Inc. (ADXS: Quote) said that preliminary data from its phase 1/2 study of ADXS-HPV in human papillomavirus associated anal cancer indicate a "clinical complete response" in all 7 patients who have completed the treatment regimen. The phase ...
 RTTNews.com1 week ago

Pacific Therapeutics Shares Article Explaining Rose Mcgowan's Kiss IPF Goodbye Campaign

/ Pacific Therapeutics Ltd. (CSE: PT) (OTC Markets: PCFTF) (Frankfurt: 1P3) (the "Company") is a clinical stage specialty pharmaceutical company focused on the repurposing and reformulation of existing FDA approved drugs for large markets. The ...

Haldia Petro shutdown spells doom for downstream sector: IPF

shadow on the future of numerous downstream plastic units in West Bengal, the Indian Plastics Federation (IPF) said. The HPL shutdown led to the closure of nearly 150 such units, rendering thousands jobless, IPF said in a statement. The HPL plant was shut ...
 Business Standard2 months ago
Securities Technology Monitor

MediciNova Announces FDA Granted Orphan Drug Designation to MN-001 (tipelukast) for Idiopathic Pulmonary Fibrosis (IPF)

LA JOLLA, Calif., Oct. 22, 2014 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ( Nasdaq:MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that the U.S.
 Town Hall1 day ago MediciNova, Inc. Announces FDA Granted Orphan Drug Designation To MN-001 (Tipelukast) For Idiopathic Pulmonary Fibrosis (IPF)  BioSpace19 hours ago MediciNova : Announces FDA Granted Orphan Drug Designation to MN-001 (tipelukast) for Idiopathic Pulmonary Fibrosis (IPF)  4 Traders1 day ago U.S. Centers for Disease Control and Prevention (CDC) Supports Recruitment for MediciNova's Clinical Trial of MN-166 (Ibudilast) in ALS  Scottrade11 hours ago

IPF sees good pre-tax profit growth - International Personal Finance saw good pre-tax profit growth in the third quarter despite weakness in Czech-Slovakia, where trading conditions proved challenging. IPF said the business delivered good underlying profit growth ...
 Stock Market Wire2 days ago IPF sees good pre-tax profit grow...  TrustNet2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less